OBJECTIVE: To investigate the long-term influence of erythrocyte transfusion on cerebral oxygenation in patients with severe traumatic brain injury. DESIGN: Prospective and observational study. SETTING: Neurotrauma intensive care unit of trauma center level I. PATIENTS: Sixty consecutive, hemodynamically stable patients with severe traumatic brain injury, pretransfusion hemoglobin<100g/l, non-bleeding and monitored through intracranial pressure and brain tissue partial pressure of oxygen (PtiO(2)) catheters were included. INTERVENTIONS: Transfusion of 1-2 units of red blood cells. MEASUREMENTS AND RESULTS: Ten sets of variables (pretransfusion, end of transfusion, and 1, 2, 3, 4, 5, 6, 12 and 24h after transfusion) were recorded, including: PtiO(2), cerebral perfusion pressure (CPP), end-tidal CO(2), peripheral saturation of oxygen, temperature, hemoglobin, lactate and PaO(2)/FiO(2) ratio. Transfusion was associated with an increase in PtiO(2) during a 6-h period, with a peak at 3h (26.2%; p=0.0001) in 78.3% of the patients. No relationship was observed between PtiO(2), CPP and hemoglobin increments. The relative increment in PtiO(2) at hour 3 was only correlated with baseline PtiO(2) (r(2) 0.166; p=0.001). All of the patients with basal PtiO(2)<15mmHg showed an increment in PtiO(2) versus 74.5% of patients with basal PtiO(2)>or=15mmHg (p<0.01, hour 3). CONCLUSIONS: Erythrocyte transfusion is associated with a variable and prolonged increment of cerebral tissue oxygenation in anemic patients with severe traumatic brain injury. Low baseline PtiO(2) levels (<15mmHg) could define those patients who benefit the most from erythrocyte transfusion.
OBJECTIVE: To investigate the long-term influence of erythrocyte transfusion on cerebral oxygenation in patients with severe traumatic brain injury. DESIGN: Prospective and observational study. SETTING:Neurotrauma intensive care unit of trauma center level I. PATIENTS: Sixty consecutive, hemodynamically stable patients with severe traumatic brain injury, pretransfusion hemoglobin<100g/l, non-bleeding and monitored through intracranial pressure and brain tissue partial pressure of oxygen (PtiO(2)) catheters were included. INTERVENTIONS: Transfusion of 1-2 units of red blood cells. MEASUREMENTS AND RESULTS: Ten sets of variables (pretransfusion, end of transfusion, and 1, 2, 3, 4, 5, 6, 12 and 24h after transfusion) were recorded, including: PtiO(2), cerebral perfusion pressure (CPP), end-tidal CO(2), peripheral saturation of oxygen, temperature, hemoglobin, lactate and PaO(2)/FiO(2) ratio. Transfusion was associated with an increase in PtiO(2) during a 6-h period, with a peak at 3h (26.2%; p=0.0001) in 78.3% of the patients. No relationship was observed between PtiO(2), CPP and hemoglobin increments. The relative increment in PtiO(2) at hour 3 was only correlated with baseline PtiO(2) (r(2) 0.166; p=0.001). All of the patients with basal PtiO(2)<15mmHg showed an increment in PtiO(2) versus 74.5% of patients with basal PtiO(2)>or=15mmHg (p<0.01, hour 3). CONCLUSIONS: Erythrocyte transfusion is associated with a variable and prolonged increment of cerebral tissue oxygenation in anemicpatients with severe traumatic brain injury. Low baseline PtiO(2) levels (<15mmHg) could define those patients who benefit the most from erythrocyte transfusion.
Authors: Timothy S Walsh; Robert J Lee; Caroline R Maciver; Magnus Garrioch; Fiona Mackirdy; Alexander R Binning; Stephen Cole; D Brian McClelland Journal: Intensive Care Med Date: 2005-11-23 Impact factor: 17.440
Authors: Richard B Weiskopf; John Feiner; Harriet Hopf; Jeremy Lieberman; Heather E Finlay; Cheng Quah; Joel H Kramer; Alan Bostrom; Pearl Toy Journal: Anesthesiology Date: 2006-05 Impact factor: 7.892
Authors: Antonio J Marín-Caballos; Francisco Murillo-Cabezas; Aurelio Cayuela-Domínguez; Jose M Domínguez-Roldán; M Dolores Rincón-Ferrari; Julio Valencia-Anguita; Juan M Flores-Cordero; M Angeles Muñoz-Sánchez Journal: Crit Care Date: 2005-10-14 Impact factor: 9.097
Authors: Santiago R Leal-Noval; Aurelio Cayuela; Victoria Arellano-Orden; Antonio Marín-Caballos; Vicente Padilla; Carmen Ferrándiz-Millón; Yael Corcia; Claudio García-Alfaro; Rosario Amaya-Villar; Francisco Murillo-Cabezas Journal: Intensive Care Med Date: 2010-05-26 Impact factor: 17.440
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel De Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Duncan Macrae; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerôme Pugin; Michael Pinsky; Peter Radermacher; Christian Richard Journal: Intensive Care Med Date: 2006-12-19 Impact factor: 17.440
Authors: Victoria A McCredie; Simone Piva; Marlene Santos; Wei Xiong; Airton Leonardo de Oliveira Manoel; Andrea Rigamonti; Gregory M T Hare; Martin G Chapman; Andrew J Baker Journal: Neurocrit Care Date: 2017-04 Impact factor: 3.210
Authors: Matthew J Sena; Ryan M Rivers; J Paul Muizelaar; Felix D Battistella; Garth H Utter Journal: Intensive Care Med Date: 2008-10-15 Impact factor: 17.440
Authors: Andreas Pape; Harry Kertscho; Jens Meier; Oliver Horn; Mohamed Laout; Max Steche; Mischa Lossen; Alf Theisen; Bernhard Zwissler; Oliver Habler Journal: Intensive Care Med Date: 2008-04-02 Impact factor: 17.440